Abstract:Abstract Introduction: Chronic inflammation has been implicated in cancer development in many tissues and has recently been associated with promoted clonal expansion in non-cancer tissues. Primary sclerosing cholangitis (PSC) is a chronic progressive disease of unknown etiology affecting the bile ducts and has been associated with a substantially increased risk of cholangiocarcinoma. Clonal dynamics in the normal bile duct and PSC epithelium remains poorly understood because of the limited accessibility to normal/inflamed bile ducts. In this study, we established a method to detect somatic mutations accumulated in the bile duct epithelium and investigated a mutation rate in normal bile duct cells and clonal expansion in PSC epithelium. Methods: We established single cell-derived organoids from bile, which were subjected to whole genome sequencing to measure the age-related mutation rate in normal epithelial cell in the bile ducts. We next established organoids from multiple sites in perihilar bile ducts and collected epithelial samples from intrahepatic bile ducts obtained by laser-capture microdissection (LCM) from patients with PSC who underwent total hepatectomy for liver transplantation, for which we performed whole exome sequencing to investigate clonal expansion in PSC-involved bile ducts. Results: In total, 14 single cell-derived organoid lines were established from 2 patients with PSC and 3 control individuals. Based on the whole genome sequencing of those organoids, the number of mutations found in non-PSC bile duct epithelium increases with age at an annual mutation rate of 34.3 mutations per genome per year, which did not substantially differ from the rate in the PSC epithelium, suggesting that the inflammatory process in PSC hardly affected the mutations in PSC epithelium. To further investigate clonal expansion in the PSC epithelium, a total of 120 bulk organoid samples from perihilar bile ducts in 3 PSC patients and 111 LCM samples from intrahepatic bile ducts in 4 PSC patients were analyzed. In perihilar bile duct-derived organoids, we detected a median of 13 [1-30] somatic mutations per exome in samples derived from perihilar bile ducts and 20 [5-41] mutations per exome in those from intrahepatic LCM samples. Most mutations were detected in a single sample but some mutation clusters were shared by adjacent samples, which expanded in an area as large as 13 mm in length. Expanded clones harbored mutations in known cancer-driver genes, such as ARID1A and KRAS, which were enriched in segmental bile ducts, suggesting their role in the clonal expansion. Conclusions: Here, we established the method to detect somatic mutations accumulated in the normal/inflamed bile duct epithelium using an organoid-based analysis of clonal somatic mutations. Our results revealed clonal expansion existing in PSC epithelium and open up a way to the better understanding of carcinogenesis in the bile duct. Citation Format: Hirona Maeda, Nobuyuki Kakiuchi, Takashi Ito, Eri Ogawa, Masahiro Shiokawa, Norimitsu Uza, Hiroko Tanaka, Yasuhito Nannya, Hideki Makishima, Yuzo Kodama, Etsuro Hatano, Satoru Miyano, Seishi Ogawa. Clonal expansion in bile duct associated with chronic inflammation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1626.

Multistage carcinogenesis in occupational cholangiocarcinoma: the impact of clonal expansion and risk estimation

Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer

Early detection of occupational cholangiocarcinoma in a high-risk patient under intensive surveillance: a case study

Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts

CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma

Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management

The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated

Establishment of a Cholangiocarcinoma Risk Evaluation Model Based on Mucin Expression Levels

Abstract 1626: Clonal expansion in bile duct associated with chronic inflammation

Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention

Multiple Cellular Origins and Molecular Evolution of Intrahepatic Cholangiocarcinoma

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare

The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma

Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study

Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance

Specific Genomic Alterations and Prognostic Analysis of Perihilar Cholangiocarcinoma and Distal Cholangiocarcinoma.

Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: A single institution retrospective study

Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report

[Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics]

Risk factors for intrahepatic cholangiocarcinoma: a systematic review and meta-analysis

Surgical Outcome and Prognostic Factors in Intrahepatic Cholangiocarcinoma